Funny how we haven't heard squat from oncofakeapharma about their plans on funding or uplisting to Nasdaq. Add that they have done ZERO with their investment in Sybleu, Zander, and Regen. This is from their last quarterly. Why so much money to Koos run businesses?
INVESTMENTS
Investment in KCL Therapeutics, Inc. Licensing Agreement 1,400,000
Investment in Regen Biopharma, Inc. Licensing Agreement 55,000
Investment in Sybleu, Inc. Licensing Agreement 237,250
Do you think oncofakeapharma will release a year end report to their shareholders explaining why they wasted so much money by giving it to Koos?
News 
Market Data 
Discover 
AI
